ProfileGDS4459 / ENSG00000167757
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 40% 36% 34% 35% 43% 41% 39% 37% 37% 37% 34% 40% 42% 36% 38% 49% 46% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.0940
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.9636
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.734
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 4435
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.1343
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.0741
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.9839
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.8337
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.8337
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.8937
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.7534
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.9740
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.1242
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9836
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.8738
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3649
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.2446